Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy

Gastroenterology
C J HealeyH Chapel

Abstract

Hepatitis C virus (HCV) infection has been associated with intravenous (IV) immunoglobulin (Ig), and plasma donations used to prepare IV Ig are now screened to prevent transmission. Thirty-six patients from the United Kingdom received infusions from a batch of anti-HCV antibody-screened intravenous Ig (Gammagard; Baxter Healthcare Ltd., Thetford, Norfolk, England) that was associated with reports of acute hepatitis C outbreak in Europe. The aim of this study was to document the epidemiology of this outbreak. Forty-six patients from the United Kingdom treated with Gammagard (34 exposed and 12 unexposed to the batch) returned epidemiological questionnaires. Eighty-two percent of the exposed patients (28 of 34) became positive for HCV RNA. Eighteen percent of the patients (6 of 34) who had infusions with this batch tested negative for HCV RNA, but 2 of the patients had abnormal liver function and subsequently seroconverted to anti-HCV antibody positive. Twenty-seven percent of the patients (9 of 34) developed jaundice, and 79% (27 of 34) had abnormal liver transferase levels. Virus isolates (n=21), including an isolate from the implicated batch, were genotype 1a and virtually identical by sequence analysis of the NS5 region, consi...Continue Reading

Citations

Jun 11, 1999·Journal of Internal Medicine·K BjøroS S Frøland
Feb 26, 2000·Clinical and Experimental Immunology·H B Gaspar, M E Conley
Jul 15, 2003·Clinical Microbiology Reviews·David K Henderson
May 29, 2004·The Journal of General Virology·Søren U NielsenGeoffrey L Toms
Nov 24, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Norbert Hubert GruenerCarl Albrecht Schirren
Dec 18, 2008·Scandinavian Journal of Gastroenterology·Helge L WaldumArne K Sandvik
Apr 7, 2009·British Journal of Haematology·Helen Chapel, Charlotte Cunningham-Rundles
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M ChristieW M Rosenberg
May 12, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mei-ying W YuRobert H Purcell
Mar 29, 2005·Zeitschrift für Rheumatologie·H MichelsF Buttgereit
Nov 27, 2014·Frontiers in Immunology·Siobhán B CashmanLynn B Dustin
Dec 9, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Sarah Louise Johnston, Rob Hollingsworth
Nov 1, 1996·Medicine·H D Ochs, C I Smith
Dec 24, 1997·Australian and New Zealand Journal of Medicine·J W Quin
Jul 1, 1997·Journal of Gastroenterology and Hepatology·D B Smith, P Simmonds
Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J Collier, J Heathcote
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E L MurphyG J Nemo
Feb 6, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Piazza
Jun 15, 2007·Clinical and Experimental Immunology·P WoodUNKNOWN UK Primary Immunodeficiency Network
May 12, 1998·The American Journal of Physiology·Y ZavrosA Shulkes
Jun 27, 1997·Biochemical and Biophysical Research Communications·S TsutsuiY Matsuzawa
Jul 13, 2000·Baillière's Best Practice & Research. Clinical Gastroenterology·S J Hadziyannis, D Vassilopoulos
Dec 6, 2006·The Journal of Hospital Infection·R-P Vonberg, P Gastmeier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.